UK & Malaysia: Healthcare News Summary (19th June)

Updated: Jun 22, 2020

Note: A hyperlink is attached in each headlines for further reading of the original news.



Table of Contents:


1. United Kingdom News 2. Malaysia News



1. UNITED KINGDOM NEWS


Headline: UK has handled coronavirus crisis 'appallingly badly', expert tells MPs

Date: 19th June 2020

Source: The National

Monthly Visitors: 263,910



Summary:

  • Professor Linda Bauld (University of Edinburgh) stated that UK ministers failed to explain that their decision only applies to England.

  • There was lack of transparency from the UK government in the early days of the pandemic.

  • Bauld elaborated that the SAGE advisory group is almost devoid of people with "on the ground public health experience."

  • Survey shows that trust in Government messaging is higher in Scotland than in England.



Headline: UK Public Health Bodies Reviewing Vitamin D's effects on Coronavirus

Date: 17th June 2020

Source: The Guardian

Monthly Visitors: 92,205,690



Summary:

  • The National Institute for Health And Care Excellence (NICE) are reviewing the potential of Vitamin D to reduce risk of Coronavirus, with support from Public Health England (PHE).

  • A professor of respiratory infection and immunity observed that Vitamin D could help the body handle viral respiratory infections, boosts the cells' ability to kill viruses, and dampen harmful inflammations (which is one of the biggest problems of COVID-19).



Headline: UK Medical Cannabis Registry launched today by Sapphire Medical Clinics

Date: 17th June 2020

Source: Health Europa

Monthly Visitors: 222,570



Summary:

  • Sapphire Medical Clinics launched its Medical Cannabis Registry initiative to expand evidence base for medical cannabis in the UK, and decrease cost of access for patients.

  • The launch will collect and analyse the patient's clinical information who are taking medical cannabis treatments for all recognised eligible conditions.

  • Patients on the scheme will have greater insights on how the treatment affects them via the Real World Evidence Platform.



2. MALAYSIA NEWS


Headline: Associations want to meet PM over MOH's new shift system

Date: 17th June 2020

Source: New Straits Times

Monthly Visitors: 1,634,940



Summary:

  • Several associations want to meet Malaysian PM on the matter of implementing the new shift system at government clinics.

  • An online survey showed that 92% of 9,320 respondents objected to the new system.


Headline: Report: Malaysia tested 'controversial' drug without harm to Covid- 19 patients

Date: 17th June 2020

Source: The Star

Monthly Visitors: 3,465,270



Summary:

  • There is a controversy about using hydroxychloroquine on patients.

  • The use of the drug became controversial as a result of reports of death due to reported arrhythmia (irregular heart rate) and cardiac arrest among patients it was given to.

  • Malaysia found a way to test hydroxychloroquine on patients with respiratory disease without harming them.

  • A reported was compiled on this matter called: "The Malaysian Response to Covid-19: Building Preparedness for 'Surge Capacity', Testing Efficiency, and Containment'.

  • Chinese expertise found lower doses of the drug is effective.

  • Hospital Sungai Buloh's Consultant Infectious Disease Physician stated that from Chinese experience, using lower dosage of the drug works.



Headline: Duopharma Biotech to expand consumer healthcare business

Date: 17th June 2020

Source: The Edge Markets

Monthly Visitors: 879,900



Summary:

  • Duopharma Biotech will move forward to expand its consumer healthcare (CHC) product portfolio and diversify into high-value biologicals and niche products.

  • The CHC business has contributed greatly to the Duopharma's performance.

  • Duopharma's Flavettes Effervescent Vitamin C is the bestseller among immunity-boosting products.

  • Duopharma is the first pharmaceutical company to commercialise erythropoietin branded as Erysaa

  • Duopharma's breast-cancer treatment drug will be launched soon.




21 views0 comments